- Home
- CIVB vs LXEO Comparison
CIVB vs LXEO Comparison
Compare CIVB & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CIVB | LXEO |
|---|---|---|
| Founded | 1884 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.9M | 418.9M |
| IPO Year | 2012 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CIVB | LXEO |
|---|---|---|
| Price | $24.92 | $5.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $26.60 | $18.44 |
| AVG Volume (30 Days) | 73.3K | ★ 629.9K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | 31.34 | ★ 39.81 |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $19,023,000.00 | $654,000.00 |
| Revenue This Year | $14.88 | N/A |
| Revenue Next Year | $5.99 | N/A |
| P/E Ratio | $9.45 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.95 | $2.43 |
| 52 Week High | $25.83 | $10.99 |
Technical Indicators
Market Signals| Indicator | CIVB | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 59.31 | 44.86 |
| Support Level | $21.39 | $5.54 |
| Resistance Level | N/A | $6.08 |
| Average True Range (ATR) | 0.74 | 0.32 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 62.67 | 23.85 |
Price Performance
Historical ComparisonAbout CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.